Back to Search Start Over

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

Source :
PR Newswire. April 10, 2024
Publication Year :
2024

Abstract

STOCKHOLM, April 10, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for Neuropsychiatric Schizophrenia Research [...]

Subjects

Subjects :
Medical research -- Health aspects
Medicine, Experimental -- Health aspects
Schizophrenia -- Health aspects
Clinical trials -- Health aspects
Psychiatric services -- Product development
GABA -- Health aspects
Business
News, opinion and commentary

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.789522527

Tools

Authors Abstract Subjects Details